Plethora Solutions
Chalgrove
About Plethora Solutions
Plethora Solutions (AIM: PLE) is a specialty pharmaceutical company dedicated to the development and marketing of products for the treatment and management of urological disorders. The diagnosis and treatment of urological conditions represent an expanding market with many poorly met medical needs that offer the significant commercial potential for new pharmaceutical products and medical devices. The Company's principal product is a treatment remedy for male premature ejaculation which obtained marketing authorization from the European Commission on 19 November 2013. Although the European MAA has been authorized by the European Commission, the information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $5.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2014)
- Ticker: lse:PLE
- Website: plethorasolutions.co.uk
- Phone: (440) 203-0775
Industries & Categories
Biotechnology, Marketing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/plethora-solutions-2324594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.